<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE HTML>
<html xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">
  <head>
    <meta content="text/html;charset=utf-8" http-equiv="Content-Type"/>
    <title>CH.FHIR.IG.CH-VACD\ch-vacd-risks-vs - FHIR v4.0.1</title>

    <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
    <meta name="author" content="http://hl7.org/fhir"/>

    <link href="fhir.css" rel="stylesheet"/>

    <!-- Bootstrap core CSS -->
    <link href="assets/css/bootstrap-fhir.css" rel="stylesheet"/>

    <!-- Project extras -->
    <link href="assets/css/project.css" rel="stylesheet"/>
    <link href="assets/css/pygments-manni.css" rel="stylesheet"/>
    <link href="assets/css/jquery-ui.css" rel="stylesheet"/>
  	<link href="assets/css/prism.css" rel="stylesheet" />
    <!-- Placeholder for child template CSS declarations -->
    <link href="assets/css/hl7.css" rel="stylesheet"/>
    <link href="assets/css/fhir.css" rel="stylesheet"/>

    <script type="text/javascript" src="fhir-table-scripts.js"> </script>

    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
    <script src="assets/js/html5shiv.js"></script>
    <script src="assets/js/respond.min.js"></script>
    <![endif]-->

    <!-- Favicons -->
    <link rel="apple-touch-icon-precomposed" sizes="144x144" href="assets/ico/apple-touch-icon-144-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="114x114" href="assets/ico/apple-touch-icon-114-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="72x72" href="assets/ico/apple-touch-icon-72-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" href="assets/ico/apple-touch-icon-57-precomposed.png"/>
    <link rel="shortcut icon" href="assets/ico/favicon.png"/>
  </head>
  <body onload="document.body.style.opacity='1'">

	  <script src="assets/js/prism.js"></script>

    <style type="text/css">h2{--heading-prefix:"58.42"}
    h3,h4,h5,h6{--heading-prefix:"58.42"}</style>
    <div id="segment-header" class="segment">  <!-- segment-header -->
      <div class="container">  <!-- container -->
        <!-- Placeholder for child template header declarations -->

            <div id="family-nav">
	<a id="logo" no-external="true" href="http://hl7.org/fhir"> <img
		alt="logo fhir" src="fhir-logo-www.png" />
	</a>
</div>

            <div id="hl7-nav">
    <a id="hl7-logo" no-external="true" href="http://www.hl7.ch">
        <img alt="visit the hl7 website" height="50" src="hl7-logo.png" />
    </a>            
</div>

        <div id="ig-status">
          <p><span style="font-size:12pt;font-weight:bold">Implementation Guide CH VACD</span><br/>2.0.0 - STU 2</p>
        </div>
      </div> <!-- /container -->
    </div>  <!-- /segment-header -->

    <div id="segment-navbar" class="segment">  <!-- segment-navbar -->
      <div id="stripe"> </div>
      <div class="container">  <!-- container -->
        <!-- HEADER CONTENT -->

        <nav class="navbar navbar-inverse">
          <!--status-bar-->
          <div class="container">
            <button data-target=".navbar-inverse-collapse" class="navbar-toggle" data-toggle="collapse" type="button">
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
              <span class="icon-bar"> </span>
            </button>
            <a class="navbar-brand hidden" href="http://hl7.org/fhir/R4/index.html">FHIR</a>
            <div class="nav-collapse collapse navbar-inverse-collapse">
              <ul xmlns="http://www.w3.org/1999/xhtml" class="nav navbar-nav">
	<!--<li><a href="toc.html">Table of Contents</a></li> -->
	<li>
		<a href="index.html">Home</a>
	</li>


	<li class="dropdown">
		<a data-toggle="dropdown" href="#" class="dropdown-toggle">
			Use Cases
			<b class="caret"></b>
		</a>
		<ul class="dropdown-menu">
			<li>
				<a href="usecases_de.html">Anwendungsfälle</a>
			</li>
			<li>
				<a href="usecases_fr.html">Les cas d'utilisation</a>
			</li>
		</ul>
	</li>
	<li class="dropdown">
		<a data-toggle="dropdown" href="#" class="dropdown-toggle">
			Documents
			<b class="caret">
			</b>
		</a>
		<ul class="dropdown-menu">
			<li>
				<a href="immunization-administration-document.html">Immunization Administration document</a>
			</li>
			<li>
				<a href="vaccination-record-document.html">Vaccination Record document</a>
			</li>
			<li>
				<a href="immunization-recommendation-request-message.html">Immunization Recommendation Request message</a>
			</li>
			<li>
				<a href="immunization-recommendation-response-message.html">Immunization Recommendation Response message</a>
			</li>
		</ul>
	</li>
	<li>
		<a href="profiles.html">Profiles</a>
	</li>
	<li>
		<a href="extensions.html">Extensions</a>
	</li>
	<li>
		<a href="terminology.html">Terminology</a>
	</li>
	<li>
		<a href="artifacts.html">Artifacts</a>
	</li>
	<li class="dropdown">
		<a data-toggle="dropdown" href="#" class="dropdown-toggle">
			Test Cases
			<b class="caret"></b>
		</a>
		<ul class="dropdown-menu">
			<li>
				<a href="TestCases.html">Overview</a>
			</li>
			<li>
				<a href="TestCases.html#a-immunizations">A Immunizations</a>
			</li>
			<li>
				<a href="TestCases.html#b-other-elements">B Other Elements</a>
			</li>
			<li>
				<a href="TestCases.html#c-correction-of-entries">C Correction of Entries</a>
			</li>
			<li>
				<a href="TestCases.html#d-conflicts-on-merging-documents">D Conflicts on merging Documents</a>
			</li>
			<li>
				<a href="TestCases.html#e-language-handling-on-merging-documents">E Language handling on merging Documents</a>
			</li>
		</ul>
	</li>
</ul>
            </div>  <!-- /.nav-collapse -->
          </div>  <!-- /.container -->
        </nav>  <!-- /.navbar -->
      <!-- /HEADER CONTENT -->
      </div>  <!-- /container -->
    </div>  <!-- /segment-navbar -->
    <!--status-bar-->

    <div id="segment-breadcrumb" class="segment">  <!-- segment-breadcrumb -->
      <div class="container">  <!-- container -->
        <ul class="breadcrumb">
          <li><a href='toc.html'><b>Table of Contents</b></a></li><li><a href='artifacts.html'><b>Artifacts Summary</b></a></li><li><b>ch-vacd-risks-vs</b></li>

        </ul>
      </div>  <!-- /container -->
    </div>  <!-- /segment-breadcrumb -->

    <a name="top"> </a>
    <div id="segment-content" class="segment">  <!-- segment-content -->
      <div class="container">  <!-- container -->
        <div class="row">
          <div class="inner-wrapper">

<div class="col-12">
  <!--ReleaseHeader--><p id="publish-box">This page is part of the CH VACD (R4) (v2.0.0: <a data-no-external="true" href="https://confluence.hl7.org/display/HL7/HL7+Balloting" title="Standard for Trial-Use">STU</a> 2) based on <a data-no-external="true" href="http://hl7.org/fhir/R4">FHIR (HL7® FHIR® Standard) R4</a>. The current version which supersedes this version is <a data-no-external="true" href="http://fhir.ch/ig/ch-vacd">6.0.0-ballot</a>.  For a full list of available versions, see the <a data-no-external="true" href="http://fhir.ch/ig/ch-vacd/history.html">Directory of published versions</a></p><!--EndReleaseHeader-->
  






<ul class="nav nav-tabs">

  <li class="active">
    <a href="#">Narrative Content</a>
  </li>


  
    <li>
      <a href="ValueSet-ch-vacd-risks-vs.xml.html">XML</a>
    </li>
  


  
    <li>
      <a href="ValueSet-ch-vacd-risks-vs.json.html">JSON</a>
    </li>
  


  
    <li>
      <a href="ValueSet-ch-vacd-risks-vs.ttl.html">TTL</a>
    </li>
  



</ul>

  <a name="root"> </a>
  <h2 id="root">ValueSet: ch-vacd-risks-vs</h2>
  <p>
    <b>Summary</b>
  </p>
  <table class="grid">
<tbody>
<tr><td>Defining URL:</td><td>http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-risks-vs</td></tr>
 <tr><td>Version:</td><td>2.0.0</td></tr>
 <tr><td>Name:</td><td>SwissRisksForImmunizations</td></tr>
 <tr><td>Status:</td><td>Active as of 2022-02-11 02:45:16+0100</td></tr>
 <tr><td>Definition:</td><td><p>The medical and exposision risks used in Switzerland.</p>
</td></tr>
 <tr><td>Publisher:</td><td>HL7 Switzerland</td></tr>
 <tr><td>Source Resource:</td><td><a href="ValueSet-ch-vacd-risks-vs.xml.html">XML</a> / <a href="ValueSet-ch-vacd-risks-vs.json.html">JSON</a> / <a href="ValueSet-ch-vacd-risks-vs.ttl.html">Turtle</a></td></tr>
</tbody></table>


  <p>
    <b>References</b>
  </p>
  
<ul>
 <li><a href="StructureDefinition-ch-vacd-medical-problems.html">CH VACD Medical Problems Profile</a></li>
 <li><a href="StructureDefinition-ch-vacd-recommendation-medical-problems.html">CH VACD Recommendation Medical Problems Profile</a></li>
</ul>


  <!-- insert intro if present -->
  



  <a name="definition"> </a>

<!-- Content Logical Definition heading in the fragment -->
  <h3>Logical Definition (CLD)</h3>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href="CodeSystem-ch-vacd-complication-risks-cs.html"><code>urn:oid:2.16.756.5.30.1.127.3.3.1</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113001">113001</a></td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114036">114036</a></td><td>ANDERE_LEBERERKRANKUNG</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114006">114006</a></td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114033">114033</a></td><td>ANDERE_NIERENERKRANKUNG</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114034">114034</a></td><td>ANDERER_KREBS</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114025">114025</a></td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114021">114021</a></td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114005">114005</a></td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114003">114003</a></td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114007">114007</a></td><td>CHRONISCHE_LEBERERKRANKUNG</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113002">113002</a></td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114015">114015</a></td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114019">114019</a></td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114020">114020</a></td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113004">113004</a></td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114037">114037</a></td><td>HAEMODIALYSEPATIENT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114038">114038</a></td><td>HAEMOPHILIE_PATIENT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114001">114001</a></td><td>HERZINSUFFIZIENZ</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113007">113007</a></td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113008">113008</a></td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113009">113009</a></td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114018">114018</a></td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114002">114002</a></td><td>KARDIOPATHIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114008">114008</a></td><td>LEBERZIRRHOSE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113012">113012</a></td><td>LYMPHOM_LEUKAEMIE_MYELOM</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-118001">118001</a></td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113014">113014</a></td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114026">114026</a></td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114022">114022</a></td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114016">114016</a></td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113018">113018</a></td><td>NEPHROTISCHES_SYNDROM</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114012">114012</a></td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113023">113023</a></td><td>NIERENINSUFFIZIENZ</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114035">114035</a></td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113035">113035</a></td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114032">114032</a></td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114028">114028</a></td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113021">113021</a></td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114004">114004</a></td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114014">114014</a></td><td>SICHELZELLANAEMIE</td></tr><tr><td><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113036">113036</a></td><td>ZOELIAKIE</td></tr></table></li><li>Include these codes as defined in <a href="CodeSystem-ch-vacd-exposure-risks-cs.html"><code>urn:oid:2.16.756.5.30.1.127.3.3.2</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213001">213001</a></td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213028">213028</a></td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213003">213003</a></td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213005">213005</a></td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213006">213006</a></td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213007">213007</a></td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213010">213010</a></td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213011">213011</a></td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213031">213031</a></td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213012">213012</a></td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213032">213032</a></td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213027">213027</a></td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213026">213026</a></td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213030">213030</a></td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213029">213029</a></td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213014">213014</a></td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213033">213033</a></td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213024">213024</a></td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213025">213025</a></td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213015">213015</a></td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213016">213016</a></td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213017">213017</a></td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213018">213018</a></td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213019">213019</a></td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213020">213020</a></td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213021">213021</a></td><td>REKRUTEN_MILITAER</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213022">213022</a></td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td></tr><tr><td><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213023">213023</a></td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td></tr></table></li></ul><p><b>Additional Language Displays</b></p><table class="codes"><tr><td><b>Code</b></td><td><b>Deutsch (Schweiz) (German (Switzerland), de)</b></td><td><b>English (United States) (English (United States), en)</b></td><td><b>French (Switzerland) (fr)</b></td><td><b>Italian (Switzerland) (it)</b></td><td><b>rm</b></td></tr><tr><td>113001</td><td>Anatomische oder funktionelle Asplenie</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td><td>Asplénie anatomique ou fonctionnelle</td><td>Asplenia anatomica o funzionale</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td></tr><tr><td>114036</td><td>andere Lebererkrankung</td><td>ANDERE_LEBERERKRANKUNG</td><td>autre maladie hépatique</td><td>altra malattia epatica</td><td>ANDERE_LEBERERKRANKUNG</td></tr><tr><td>114006</td><td>Andere Lungenerkrankungen (z.B. Mukoviszidose, Asthma bronchiale, etc.)</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td><td>Autres maladies pulmonaires (ex : mucoviscidose, asthme traité par aérosols, etc)</td><td>Altre malattie polmonari (p.es. mucoviscidosi, asmatrattata con aerosol, ecc.)</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td></tr><tr><td>114033</td><td>Andere Nierenerkrankung</td><td>ANDERE_NIERENERKRANKUNG</td><td>autre maladie des reins</td><td>altra malattia renale</td><td>ANDERE_NIERENERKRANKUNG</td></tr><tr><td>114034</td><td>Anderer Krebs</td><td>ANDERER_KREBS</td><td>autre cancer</td><td>altro cancro</td><td>ANDERER_KREBS</td></tr><tr><td>114025</td><td>Angeborene Immundefizienz, variables Immundefektsyndrom, defizitäre Antwort auf Polysaccharide</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td><td>Immunodéficience congénitale, immunodéficience commune variable, déficit réponse aux polysaccharidiques</td><td>Immunodeficienza congenita, immunodeficienza comune variabile, deficit di risposta ai polisaccaridi</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td></tr><tr><td>114021</td><td>Autoimmunkrankheit, welche eine Immunsuppression erfordert</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td><td>Maladie auto-immune exigeant vraisemblablement une immunosuppression</td><td>Malattia autoimmune che richiede probabilmente una immunosoppressione</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td></tr><tr><td>114005</td><td>Bronchiektasen durch Antikörpermangel</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td><td>Bronchiectasies sur carence en anticorps</td><td>Bronchiettasie su carenza in anticorpi</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td></tr><tr><td>114003</td><td>Chronisch obstruktive Pneumopathie</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td><td>Pneumopathie chronique obstructive</td><td>Pneumopatia cronica ostruttiva</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td></tr><tr><td>114007</td><td>Chronische Lebererkrankung</td><td>CHRONISCHE_LEBERERKRANKUNG</td><td>Maladie hépatique chronique</td><td>Malattia epatica cronica</td><td>CHRONISCHE_LEBERERKRANKUNG</td></tr><tr><td>113002</td><td>Cochleaimplantat, in situ oder geplant</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td><td>Implant cochléaire, in situ ou planifié</td><td>Impianto cocleare, in situ o pianificato</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td></tr><tr><td>114015</td><td>Diabetes mit Auswirkung auf die Funktion von Herz, Lungen oder Nieren</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td><td>Diabète avec répercussion sur la fonction cardiaque, pulmonaire ou rénale</td><td>Diabete con ripercussioni sulla funzione cardiopolmonare o renale</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td></tr><tr><td>114019</td><td>Empfänger einer Solidorgantransplantation</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td><td>Receveurs d'une transplantation d'organe solide</td><td>Riceventi di un trapianto d'organo solido</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td></tr><tr><td>114020</td><td>Empfänger einer Stammzelltransplantation</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td><td>Receveurs de cellules souches hématopoïétiques</td><td>Riceventi di cellule staminali ematopoietiche</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td></tr><tr><td>113004</td><td>Geburt vor der 33. Schwangerschaftswoche oder Geburtsgewicht &lt; 1500g</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td><td>Naissance avant la 33e semaine de grossesse ou poids de naissance &lt;1500g</td><td>Nascita prima della 33a settimana di gravidanza o peso alla nascita &lt;1500g</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td></tr><tr><td>114037</td><td>Hämodialysepatient</td><td>HAEMODIALYSEPATIENT</td><td>Personnes dialysées</td><td>Persone in dialisi</td><td>HAEMODIALYSEPATIENT</td></tr><tr><td>114038</td><td>Hämophilie Patient</td><td>HAEMOPHILIE_PATIENT</td><td>Personnes hémophiles</td><td>Persone affette da emofilia</td><td>HAEMOPHILIE_PATIENT</td></tr><tr><td>114001</td><td>Herzinsuffizienz</td><td>HERZINSUFFIZIENZ</td><td>Insuffisance cardiaque</td><td>Insufficienza cardiaca</td><td>HERZINSUFFIZIENZ</td></tr><tr><td>113007</td><td>Herzkrankheiten (chronische, kongenitale Missbildungen)</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td><td>Cardiopathies chroniques, malformations congénitales</td><td>Cardiopatie croniche, malformazioni congenite</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td></tr><tr><td>113008</td><td>HIV Infektion mit CD4-Zellen &gt;= 15 % (Erwachsene: &gt;= 200 / µl)</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td><td>Infection à VIH avec CD4 &gt;= 15% (Adultes : &gt;= 200 / µl)</td><td>Infezione HIV con CD4 &gt;= 15% (Adulti : &gt;= 200 / µl)</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td></tr><tr><td>113009</td><td>HIV Infektion mit CD4-Zellen &lt; 15 % (Erwachsene: &lt; 200 / µl)</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td><td>Infection à VIH avec CD4 &lt; 15% (Adultes : &lt; 200 / µl)</td><td>Infezione HIV con CD4 &lt; 15% (Adulti : &lt; 200 / µl)</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td></tr><tr><td>114018</td><td>Kandidaten für eine Solidorgantransplantation</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td><td>Candidats à une transplantation d'organe solide</td><td>Candidati a un trapianto d'organo solido</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td></tr><tr><td>114002</td><td>Kardiopathie, angeborene Fehlbildung</td><td>KARDIOPATHIE</td><td>Cardiopathie, malformation congénitale</td><td>Cardiopatia, malformazione congenita</td><td>KARDIOPATHIE</td></tr><tr><td>114008</td><td>Leberzirrhose</td><td>LEBERZIRRHOSE</td><td>Cirrhose hépatique</td><td>Cirrosi epatica</td><td>LEBERZIRRHOSE</td></tr><tr><td>113012</td><td>Lymphom, Leukämie, Myelom</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td><td>Lymphome, leucémie, myélome</td><td>Linfoma, leucemia, mieloma</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td></tr><tr><td>118001</td><td>Lymphom, Leukämie, Myelom während klinischer Remission</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td><td>Lymphome, leucémie, myélome durant une rémission clinique</td><td>Linfoma, leucemia, mieloma durante una remissione clinica</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td></tr><tr><td>113014</td><td>Mangel an Mannose-bindendem Lektin</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td><td>Déficit en lectine liant le mannose</td><td>Deficit di lectina legante il mannosio</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td></tr><tr><td>114026</td><td>Mangel im klassischen oder alternativen Weg der Komplementaktivierung</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td><td>Déficit en facteurs de la voie alterne ou terminale du complément</td><td>Deficit in fattori della via alterna o terminale del complemento</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td></tr><tr><td>114022</td><td>Medikamentöse Immunosuppression (inkl. systemische Langzeitkortikoidtherapie und Radiotherapie)</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td><td>Immunosuppression médicamenteuse (y c. corticothérapie de longue durée par voie générale et radiothérapie)</td><td>Immunosoppressione medicamentosa (compresa una corticoterapia di lunga durata per via generale e una radioterapia)</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td></tr><tr><td>114016</td><td>Morbide Adipositas (BMI &gt;= 40)</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td><td>Obésité morbide (IMC &gt;= 40)</td><td>Obesità patologica (IMC &gt;= 40)</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td></tr><tr><td>113018</td><td>Nephrotisches Syndrom</td><td>NEPHROTISCHES_SYNDROM</td><td>Syndrome néphrotique</td><td>Sindrome nefrosica</td><td>NEPHROTISCHES_SYNDROM</td></tr><tr><td>114012</td><td>Neuromuskuläre Krankheit (Falls Auswirkungen auf Herz-, Lungen- oder Nierenfunktion)</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td><td>Maladie neuromusculaire (Si répercussion sur la fonction cardiaque, pulmonaire ou rénale)</td><td>Malattia neuromuscolare (Se ripercussione sulla funzione cardiaca, polmonare o renale)</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td></tr><tr><td>113023</td><td>Niereninsuffizienz</td><td>NIERENINSUFFIZIENZ</td><td>Insuffisance rénale</td><td>Insufficienza renale</td><td>NIERENINSUFFIZIENZ</td></tr><tr><td>114035</td><td>Protein-S oder Protein-C Defizit</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td><td>déficit en protéine S et protéine C</td><td>deficit di proteina S e proteina C</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td></tr><tr><td>113035</td><td>Rheumatismus oder Autoimmunkrankheit, welche eine Immunsuppression bedingt</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td><td>Maladie rhumatismale ou auto-immune allant nécessiter une immunosuppression</td><td>Malattia reumatica o autoimmune che presto richiederà l'immunosoppressione</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td></tr><tr><td>114032</td><td>Schädelbasisfraktur /-Missbildung, zerebrospinale Liquorfistel</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td><td>Fracture ou malformation de la base du crâne, fistule de liquide céphalo-rachidien</td><td>Frattura o malformazione della base del cranio, fistola di liquido cerebrospinale</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td></tr><tr><td>114028</td><td>Schwangerschaft und post-partum Periode</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td><td>Grossesse et post-partum</td><td>Gravidanza e post-parto</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td></tr><tr><td>113021</td><td>Schwere Neurodermitis beim Kind</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td><td>Eczema sévère chez l’enfant</td><td>Eczema severo nel bambino</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td></tr><tr><td>114004</td><td>Schweres Asthma: bei verlängerter oder häufiger Behandlung mit oralen Steroiden</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td><td>Asthme sévère : si traitement prolongé ou fréquent par des corticoïdes oraux</td><td>Asma severa : se trattamento prolungato o frequente con corticoidi orali</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td></tr><tr><td>114014</td><td>Sichelzellanämie</td><td>SICHELZELLANAEMIE</td><td>Anémie falciforme</td><td>Anemia falciforme</td><td>SICHELZELLANAEMIE</td></tr><tr><td>113036</td><td>Zöliakie</td><td>ZOELIAKIE</td><td>Coeliaquie</td><td>Celiachia</td><td>ZOELIAKIE</td></tr><tr><td>213001</td><td>Beschäftigte im Gesundheitswesen</td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td><td>Personnel médical et soignant</td><td>Personale medico e di cura</td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td></tr><tr><td>213028</td><td>Enge Kontaktpersonen von Meningokokken-Erkrankten</td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td><td>Méningocoques dans l'entourage</td><td>Meningococco nell'entourage</td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td></tr><tr><td>213003</td><td>Erwachsene und Kinder ab 6 Jahren, die in Endemiegebieten wohnen oder sich teilweise dort aufhalten</td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td><td>Adultes et enfants dès 6 ans qui résident ou séjournent temporairement dans des territoires endémiques</td><td>Adulti e bambini a partire dai 6 anni che risiedono o soggiornano in regioni endemiche</td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td></tr><tr><td>213005</td><td>Familienangehörige von Personen mit einem erhöhten Risiko</td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td><td>Entourage familial des personnes à risque accru de complications</td><td>Entourage famigliare di persone a maggiore rischio di complicazioni</td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td></tr><tr><td>213006</td><td>Fledermausforscher und -schützer</td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td><td>Scientifiques effectuant des recherches sur les chiroptères, protecteurs ou amateurs de chauves-souris</td><td>Ricercatori che svolgono ricerche sui chirotteri, protettori o appassionati di pipistrelli</td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td></tr><tr><td>213007</td><td>Geistig behinderte Personen in Heimen und deren BetreuerInnen</td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td><td>Personnes handicapées mentales et personnel des institutions pour handicapés mentaux</td><td>Persone disabili mentali e personale degli istituti per disabili mentali</td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td></tr><tr><td>213010</td><td>Kanalisationsarbeiter und Angestellte von Kläranlagen</td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td><td>Travailleurs des canalisationset des stations d’épuration</td><td>Personale addetto alla manutenzione delle fognature e delle stazioni di depurazione</td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td></tr><tr><td>213011</td><td>Kinder aus Ländern mit mittlerer und hoher Endemizität, die in der Schweiz leben und für einen vorübergehenden Aufenthalt in ihr Herkunftsland zurückkehren</td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td><td>Enfants originaires de pays de moyenne et haute endémicité vivant en Suisse et retournant dans leurs pays pour des séjours temporaires</td><td>Bambini originari di paesi di media ed elevata endemicità che vivono in Svizzera e che ritornano nel loro paese per dei soggiorni temporanei</td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td></tr><tr><td>213031</td><td>Kinderkrippe / Hort vor 5 Monaten</td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td><td>Crèche / garderie avant 5 mois</td><td>Asilo nido prima di 5 mesi</td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td></tr><tr><td>213012</td><td>Konsumenten von injizierbaren Drogen und deren Kontaktpersonen</td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td><td>Consommateurs de drogues injectables et personnes à leur contact</td><td>Consumatori di droghe iniettabili e persone a loro contatto</td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td></tr><tr><td>213032</td><td>Kontaktpersonen von einer schwangeren Frau</td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td><td>Entourage d ' une femme enceinte</td><td>Entourage di una donna incinta</td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td></tr><tr><td>213027</td><td>Kontaktpersonen von Hepatitis-A-Erkrankten</td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td><td>Hépatite A dans l'entourage</td><td>Epatite A nell'entourage</td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td></tr><tr><td>213026</td><td>Kontaktpersonen von Hepatitis-B-Erkrankten</td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td><td>Hépatite B dans l'entourage</td><td>Epatite B nell'entourage</td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td></tr><tr><td>213030</td><td>Laborpersonal mit Bakterien-Expositionsrisiko</td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td><td>Personnel de laboratoire exposé aux bactéries</td><td>Personale di laboratorio esposto ai batteri</td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td></tr><tr><td>213029</td><td>Laborpersonal mit Virus-Expositionsrisiko</td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td><td>Personnel de laboratoire exposé aux virus</td><td>Personale di laboratorio esposto ai virus</td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td></tr><tr><td>213014</td><td>Männer, die mit Männern Geschlechtsverkehr haben</td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td><td>Hommes ayant des relations sexuelles avec d’autres hommes</td><td>Uomini che hanno rapporti sessuali con altri uomini</td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td></tr><tr><td>213033</td><td>Mitarbeitende von Kinderkrippen</td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td><td>Professionnels de la petite enfance</td><td>Professionisti della prima infanzia</td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td></tr><tr><td>213024</td><td>Neugeborene und Säuglinge unter 12 Monaten aus Ländern mit hoher Tuberkulose prävalenz, die wahrscheinlich wieder dorthin zurückkehren (in ihrem ersten Lebensjahr )</td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td><td>Nouveau - nés ou nourrissons &lt; 12 mois originaire d’un pays à haute endémie et susceptibles d’y retourner dans leur 1ère année de vie</td><td>Neonati o lattanti &lt; 12 mesi originari di un paese a elevata endemia e suscettibili di ritornarci nel loro primo anno di vita</td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td></tr><tr><td>213025</td><td>Neugeborene von HBsAg-positiven Müttern</td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td><td>Nouveau-nés de mères HBsAg positives</td><td>Neonati di madri HBsAg positive</td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td></tr><tr><td>213015</td><td>Patientinnen und Patienten in Pflegeheimen und in Einrichtungen für Personen mit chronischen Erkrankungen</td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td><td>Patients résidant dans une maison de soins ou dans un établissement pour malades chroniques</td><td>Ospiti di una casa di cura o di un istituto per malati cronici</td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td></tr><tr><td>213016</td><td>Personen aus Ländern mit hoher oder intermediärer Hepatitis-B-Endemizität</td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td><td>Personnes provenant de zones d’endémie haute ou intermédiaire pour l’hépatite B</td><td>Persone provenienti da zone di endemicità elevata o intermedia per l’ epatite B</td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td></tr><tr><td>213017</td><td>Personen mit einer sexuell übertragbaren Krankheit</td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td><td>Personnes consultant pour une maladie sexuellement transmissible</td><td>Persone che consultano per una malattia sessualmente trasmissibile</td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td></tr><tr><td>213018</td><td>Personen mit engem Kontakt zu Personen aus Ländern mit hoher Endemizität</td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td><td>Personnes en contact étroit avec des personnes en provenance de pays de haute endémicité</td><td>Persone a stretto contatto con delle persone provenienti da paesi di endemicità elevata</td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td></tr><tr><td>213019</td><td>Personen mit häufig wechselnden Sexualpartnern</td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td><td>Personnes changeant souvent de partenaires sexuels</td><td>Persone che cambiano spesso partner sessuale</td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td></tr><tr><td>213020</td><td>Personen mit regelmässigem Kontakt (beruflich / familiär) zu Säuglingen &lt; 6 Monaten, schwangere Frauen</td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td><td>Personnes en contact professionnel ou familial régulier avec des nourrissons &lt; 6 mois, femmes enceintes</td><td>Personale in contatto professionale o famigliare con dei lattanti di meno di 6 mesi o con donne incinte</td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td></tr><tr><td>213021</td><td>Rekruten (Militär)</td><td>REKRUTEN_MILITAER</td><td>Recrues (militaires)</td><td>Reclute (militari)</td><td>REKRUTEN_MILITAER</td></tr><tr><td>213022</td><td>Sozialarbeiter, Gefängnispersonal und Polizeiangestellte mit häufigem Kontakt zu Konsumenten von injizierbaren Drogen</td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td><td>Travailleurs sociaux, personnel des prisons et de la police en contact fréquent avec des consommateurs de drogues injectables</td><td>Lavoratori nel campo socio - educativo o della sicurezza (carceri, polizia) a contatto frequente con dei consumatori di droghe iniettabili</td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td></tr><tr><td>213023</td><td>Tierärzte (inkl. Studenten, Praxisangestellte)</td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td><td>Vétérinaires (étudiants : assistants vétérinaires)</td><td>Veterinari (studenti, assistenti veterinari)</td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td></tr></table></div>

  <p>&#160;</p>
  <a name="expansion"> </a>
  <h3 id="expansion">Expansion</h3>

  <div xmlns="http://www.w3.org/1999/xhtml"><p>This value set contains 69 concepts</p><div style="border: black 1px dotted; background-color: #EEEEEE; padding: 8px; margin-bottom: 8px"><p>Expansion based on: </p><ul><li><a href="CodeSystem-ch-vacd-exposure-risks-cs.html">Swiss Exposure Risks Codesystem v2.0.0 (CodeSystem)</a></li><li><a href="CodeSystem-ch-vacd-complication-risks-cs.html">Swiss Complication Risks Codesystem v2.0.0 (CodeSystem)</a></li></ul></div><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>System</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113001"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113001">113001</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANATOMISCHE_ODER_FUNKTIONELLE_ASPLENIE</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114036"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114036">114036</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANDERE_LEBERERKRANKUNG</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114006"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114006">114006</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANDERE_LUNGENERKRANKUNGEN_ZB_MUKOVISZIDOSE_ASTHMA_BRONCHIALE_ETC</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114033"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114033">114033</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANDERE_NIERENERKRANKUNG</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114034"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114034">114034</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANDERER_KREBS</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114025"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114025">114025</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ANGEBORENE_IMMUNDEFIZIENZ_VARIABLES_IMMUNDEFEKTSYNDROM_DEFIZITAERE_ANTWORT_AUF_POLYSACCHARIDE</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114021"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114021">114021</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_ERFORDERT</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114005"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114005">114005</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>BRONCHIEKTASEN_DURCH_ANTIKOERPERMANGEL</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114003"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114003">114003</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>CHRONISCH_OBSTRUKTIVE_PNEUMOPATHIE</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114007"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114007">114007</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>CHRONISCHE_LEBERERKRANKUNG</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113002"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113002">113002</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>COCHLEAIMPLANTAT_IN_SITU_ODER_GEPLANT</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114015"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114015">114015</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>DIABETES_MIT_AUSWIRKUNG_AUF_DIE_FUNKTION_VON_HERZ_LUNGEN_ODER_NIEREN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114019"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114019">114019</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>EMPFAENGER_EINER_SOLIDORGANTRANSPLANTATION</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114020"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114020">114020</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>EMPFAENGER_EINER_STAMMZELLTRANSPLANTATION</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113004"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113004">113004</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>GEBURT_VOR_DER_33_SCHWANGERSCHAFTSWOCHE_ODER_GEBURTSGEWICHT_GROESSER_1500G</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114037"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114037">114037</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HAEMODIALYSEPATIENT</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114038"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114038">114038</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HAEMOPHILIE_PATIENT</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114001"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114001">114001</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HERZINSUFFIZIENZ</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113007"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113007">113007</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HERZKRANKHEITEN_CHRONISCHE_KONGENITALE_MISSBILDUNGEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113008"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113008">113008</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_GROESSER_GLEICH_15_PROZENT_ERWACHSENE_GROESSER_GLEICH_200_PRO_UL</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113009"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113009">113009</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>HIV_INFEKTION_MIT_CD4_ZELLEN_KLEINER_15_PROZENT_ERWACHSENE_KLEINER_200_PRO_UL</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114018"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114018">114018</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>KANDIDATEN_FUER_EINE_SOLIDORGANTRANSPLANTATION</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114002"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114002">114002</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>KARDIOPATHIE</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114008"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114008">114008</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>LEBERZIRRHOSE</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113012"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113012">113012</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>LYMPHOM_LEUKAEMIE_MYELOM</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-118001"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-118001">118001</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>LYMPHOM_LEUKAEMIE_MYELOM_WAEHREND_KLINISCHER_REMISSION</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113014"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113014">113014</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>MANGEL_AN_MANNOSE_BINDENDEM_LEKTIN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114026"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114026">114026</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>MANGEL_IM_KLASSISCHEN_ODER_ALTERNATIVEN_WEG_DER_KOMPLEMENTAKTIVIERUNG</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114022"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114022">114022</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>MEDIKAMENTOESE_IMMUNOSUPPRESSION_INKL_SYSTEMISCHE_LANGZEITKORTIKOIDTHERAPIE_UND_RADIOTHERAPIE</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114016"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114016">114016</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>MORBIDE_ADIPOSITAS_BMI_GROESSER_40</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113018"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113018">113018</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>NEPHROTISCHES_SYNDROM</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114012"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114012">114012</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>NEUROMUSKULAERE_KRANKHEIT_FALLS_AUSWIRKUNGEN_AUF_HERZ__LUNGEN_ODER_NIERENFUNKTION</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113023"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113023">113023</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>NIERENINSUFFIZIENZ</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114035"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114035">114035</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>PROTEIN_S_ODER_PROTEIN_C_DEFIZIT</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113035"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113035">113035</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>RHEUMATISMUS_ODER_AUTOIMMUNKRANKHEIT_WELCHE_EINE_IMMUNSUPPRESSION_BEDINGT</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114032"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114032">114032</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SCHAEDELBASISFRAKTUR_MISSBILDUNG_ZEREBROSPINALE_LIQUORFISTEL</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114028"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114028">114028</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SCHWANGERSCHAFT_UND_POST_PARTUM_PERIODE</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113021"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113021">113021</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SCHWERE_NEURODERMITIS_BEIM_KIND</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114004"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114004">114004</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SCHWERES_ASTHMA_BEI_VERLAENGERTER_ODER_HAEUFIGER_BEHANDLUNG_MIT_ORALEN_STEROIDEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-114014"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-114014">114014</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>SICHELZELLANAEMIE</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.1-113036"> </a><a href="CodeSystem-ch-vacd-complication-risks-cs.html#ch-vacd-complication-risks-cs-113036">113036</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.1</td><td>ZOELIAKIE</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213001"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213001">213001</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>BESCHAEFTIGTE_IM_GESUNDHEITSWESEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213028"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213028">213028</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>ENGE_KONTAKTPERSONEN_VON_MENINGOKOKKEN_ERKRANKTEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213003"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213003">213003</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>ERWACHSENE_UND_KINDER_AB_6_JAHREN_DIE_IN_ENDEMIEGEBIET_WOHNEN_ODER_SICH_TEILWEISE_DORT_AUFHALTEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213005"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213005">213005</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>FAMILIENANGEHOERIGE_VON_PERSONEN_MIT_EINEM_ERHOEHTEN_RISIKO</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213006"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213006">213006</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>FLEDERMAUSFORSCHER_UND_SCHUETZER</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213007"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213007">213007</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>GEISTIG_BEHINDERTE_PERSONEN_IN_HEIMEN_UND_DEREN_BETREUERINNEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213010"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213010">213010</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KANALISATIONSARBEITER_UND_ANGESTELLTE_VON_KLAERANLAGEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213011"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213011">213011</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KINDER_AUS_LAENDERN_MIT_MITTLERER_UND_HOHER_ENDEMIZITAET_DIE_IN_DER_SCHWEIZ_LEBEN_UND_FUER_EINEN_VORUEBERGEHENDEN_AUFENTHALT_IN_IHR_HERKUNFTSLAND_ZURUECKKEHREN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213031"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213031">213031</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KINDERKRIPPE_HORT_VOR_5_MONATEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213012"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213012">213012</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KONSUMENTEN_VON_INJIZIERBAREN_DROGEN_UND_DEREN_KONTAKTPERSONEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213032"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213032">213032</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KONTAKTPERSONEN_VON_EINER_SCHWANGEREN_FRAU</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213027"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213027">213027</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KONTAKTPERSONEN_VON_HEPATITIS_A_ERKRANKTEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213026"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213026">213026</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>KONTAKTPERSONEN_VON_HEPATITIS_B_ERKRANKTEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213030"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213030">213030</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>LABORPERSONAL_MIT_BAKTERIEN_EXPOSITIONSRISIKO</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213029"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213029">213029</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>LABORPERSONAL_MIT_VIRUS_EXPOSITIONSRISIKO</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213014"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213014">213014</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>MAENNER_DIE_MIT_MAENNERN_GESCHLECHTSVERKEHR_HABEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213033"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213033">213033</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>MITARBEITENDE_VON_KINDERKRIPPEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213024"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213024">213024</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>NEUGEBORENE_UND_SAEUGLINGE_UNTER_12_MONATEN_AUS_LAENDERN_MIT_HOHER_TUBERKULOSE_PRAEVALENZ_DIE_WAHRSCHEINLICH_WIEDER_DORTHIN_ZURUECKKEHREN_IN_IHREM_ERSTEN_LEBENSJAHR</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213025"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213025">213025</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>NEUGEBORENE_VON_HBSAG_POSITIVEN_MUETTERN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213015"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213015">213015</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PATIENTINNEN_UND_PATIENTEN_IN_PFLEGEHEIMEN_UND_IN_EINRICHTUNGEN_FUER_PERSONEN_MIT_CHRONISCHEN_ERKRANKUNGEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213016"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213016">213016</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_AUS_LAENDERN_MIT_HOHER_ODER_INTERMEDIAERER_HEPATITIS_B_ENDEMIZITAET</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213017"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213017">213017</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_MIT_EINER_SEXUELL_UEBERTRAGBAREN_KRANKHEIT</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213018"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213018">213018</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_MIT_ENGEM_KONTAKT_ZU_PERSONEN_AUS_LAENDERN_MIT_HOHER_ENDEMIZITAET</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213019"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213019">213019</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_MIT_HAEUFIG_WECHSELNDEN_SEXUALPARTNERN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213020"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213020">213020</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>PERSONEN_MIT_REGELMAESSIGEM_KONTAKT_BERUFLICH_ODER_FAMILIAER_ZU_SAEUGLINGEN_UNTER_6_MONATEN_ODER_SCHWANGERE_FRAUEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213021"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213021">213021</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>REKRUTEN_MILITAER</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213022"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213022">213022</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>SOZIALARBEITER_GEFAENGNISPERSONAL_UND_POLIZEIANGESTELLTE_MIT_HAEUFIGEM_KONTAKT_ZU_KONSUMENTEN_VON_INJIZIERBAREN_DROGEN</td></tr><tr><td style="white-space:nowrap"><a name="urn-oid-2.16.756.5.30.1.127.3.3.2-213023"> </a><a href="CodeSystem-ch-vacd-exposure-risks-cs.html#ch-vacd-exposure-risks-cs-213023">213023</a></td><td>urn:oid:2.16.756.5.30.1.127.3.3.2</td><td>TIERAERZTE_INKL_STUDENTEN_PRAXISANGESTELLTE</td></tr></table></div>

  <hr/>
  <p>
    Explanation of the columns that may appear on this page:
  </p>
  <table class="grid">
    <tr>
      <td>Level</td>
      <td>A few code lists that FHIR defines are hierarchical - each code is assigned a level.
          In this scheme, some codes are under other codes, and imply that the code they are under also applies</td>
    </tr>
    <tr>
      <td>System</td>
      <td>The source of the definition of the code (when the value set draws in codes defined elsewhere)</td>
    </tr>
    <tr>
      <td>Code</td>
      <td>The code (used as the code in the resource instance)</td>
    </tr>
    <tr>
      <td>Display</td>
      <td>The display (used in the <i>display</i> element of a <a href="http://hl7.org/fhir/R4/datatypes.html#Coding">Coding</a>). If there is no display, implementers should not simply display the code, but map the concept into their application</td>
    </tr>
    <tr>
      <td>Definition</td>
      <td>An explanation of the meaning of the concept</td>
    </tr>
    <tr>
      <td>Comments</td>
      <td>Additional notes about how to use the code</td>
    </tr>
  </table>

  <!-- insert notes if present -->
  



  

</div>
        </div>  <!-- /inner-wrapper -->
      </div>  <!-- /row -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-content -->

  <script type="text/javascript" src="assets/js/jquery.js"> </script>     <!-- note keep space here, otherwise it will be transformed to empty tag -> fails -->
  <script type="text/javascript" src="assets/js/jquery-ui.min.js"> </script>

  <script type="text/javascript">
    $(document).ready(function(){
      if(window.location.hash != "") {
          $('a[href="' + window.location.hash + '"]').click()
      }
    });
  </script>
  <a name="bottom"> </a>
  <div id="segment-footer" igtool="footer" class="segment">  <!-- segment-footer -->
    <div class="container">  <!-- container -->

      <div class="inner-wrapper">
        <p>
          IG &#169; 2021+ <a style="color:var(--footer-hyperlink-text-color)" href="https://www.hl7.ch/">HL7 Switzerland</a>.  Package ch.fhir.ig.ch-vacd#2.0.0 based on <a style="color: var(--footer-hyperlink-text-color)" href="http://hl7.org/fhir/R4/">FHIR 4.0.1</a>. Generated <span title="Fri, Feb 11, 2022 14:45+0100">2022-02-11</span>
          <br/>
          <span style="color: var(--footer-highlight-text-color)"></span>
                      Links: <a style="color: var(--footer-hyperlink-text-color)" href="toc.html">Table of Contents</a> |
                 <a style="color: var(--footer-hyperlink-text-color)" href="qa.html">QA Report</a>
                 
                

| <a style="color: #81BEF7" target="_blank" href="https://docs.google.com/forms/d/e/1FAIpQLSejY5cinbQ4kHgGKMhncYu0mPuWb7euUkxfeXZeiUCFFa4k6g/viewform?usp=sf_link&amp;entry%2E1353807103=ch.fhir.ig.ch-vacd%232.0.0%20/ValueSet-ch-vacd-risks-vs.html&amp;entry%2E247644557=ch-vacd-risks-vs">Propose a change</a>

          </span>
        </p>
      </div>  <!-- /inner-wrapper -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-footer -->
  
  <div id="segment-post-footer" class="segment hidden">  <!-- segment-post-footer -->
    <div class="container">  <!-- container -->
    </div>  <!-- /container -->
  </div>  <!-- /segment-post-footer -->
  
  <!-- JS and analytics only. -->
  <!-- Bootstrap core JavaScript
  ================================================== -->
  <!-- Placed at the end of the document so the pages load faster -->
  <script type="text/javascript" src="assets/js/bootstrap.min.js"> </script>
  <script type="text/javascript" src="assets/js/respond.min.js"> </script>
  <script type="text/javascript" src="assets/js/anchor.min.js"> </script>
  <script>anchors.options.visible = 'hover'
anchors.add()</script>
  
<!-- feedback form - Google forms -->
<!-- v0.1, 2021-01-09 -->


  


  



<!-- / feedback form  -->

  <!-- Analytics Below
  ================================================== -->
  </body>
</html>

